Our High Dose Capsules are finally available on the website!
🐝
I originally started to offer the high dose CBD capsules for cancer patients because of what the studies were saying… and it's worth reading!
🌲
According to Cancers, a peer reviewed medical journal, CB1 and CB2 receptors were found inside cancer cells and shown to be effective at showing cytotoxic effects (harming the bad cancer cells) and tumor suppressing properties (shown to shrink and eliminate tumors) in colon cancer, liver cancer (hepatocellular carcinoma), Hodgkin lymphoma, ovarian cancer, breast cancer, and gliomas (Seltzer, Watters, MacKenzie, Granat, Zhang, 2020).
♻️
Delta-9 THC and CBD were also shown to inhibit DNA synthesis, growth, and metastasis (how cancer cells grow, multiply, and spread) and it was shown to be effective against lung cancer (lung adenocarcinoma), glioma, breast, pancreas, prostate, colorectal carcinoma, and lymphoma (Seltzer, Watters, MacKenzie, Granat, Zhang, 2020).
🐝
According to the British Journal of Clinical Pharmacology, a peer reviewed medical journal, they mentioned how excellent the safety profile of CBD is, and it has a low risk for significant drug interactions (Millar, et al., 2019). Millar et al. (2019) also concluded that there is no risk for dependence or abuse for CBD, which can help others understand that there won’t be any addictive behaviors involved (Millar, et al., 2019).
🌲
There are sick people suffering from these different types of cancers, all while there is published medical journals discussing the anti-cancer, anti-tumor, and tumor suppressing properties of CBD and THC which is exactly why I offer this to the world (Seltzer, Watters, MacKenzie, Granat, Zhang, 2020).
♻️
I am not going to lie, I kind of do fear spreading this information to the world because it goes against the grain, but this information needs to get out to the sick people that are suffering. It is most definitely a risk for myself and the business, but it is a risk I am willing to take.
Bee Happy,
Brandon Farless
🐝🌲♻️
References
Millar, S. A., Stone, N. L., Bellman, Z. D., Yates, A. S., England, T. J., & O'Sullivan, S. E. (2019). A systematic review of cannabidiol dosing in clinical populations. British journal of clinical pharmacology, 85(9), 1888–1900. https://doi.org/10.
Seltzer, E. S., Watters, A. K., MacKenzie, D., Jr, Granat, L. M., & Zhang, D. (2020). Cannabidiol (CBD) as a Promising Anti-Cancer Drug. Cancers, 12(11), 3203. https://doi.org/10.3390/
* This information is for educational purposes only and simply sharing of the information pertained to these studies. No medical claims or advice is being given.
